Last updated：--
View ChartEnzyme (MLN) is a decentralized asset management platform built on Ethereum, positioning itself as global infrastructure for tokenized finance. Originally launched in 2017 under the name Melon Protocol, the project rebranded to Enzyme in 2020. The platform enables individuals and institutions to create, manage, and scale various investment strategies, including discretionary strategies, automated bot strategies, exchange-traded funds, and market-making operations. Enzyme provides a unified interface for accessing digital assets and DeFi protocols, emphasizing security through second-generation smart contracts that undergo rigorous testing and auditing before mainnet deployment. The MLN token serves governance and protocol fee functions, with a circulating supply of approximately 3.27 million tokens across multiple data sources. The project has evolved significantly, introducing Enzyme Onyx as a modular architecture with open APIs for tokenized fund infrastructure, and has expanded support to Ethereum Virtual Machine networks, Rayls, and Canton. With over eight years of operational history in decentralized finance, Enzyme continues to develop institutional-grade infrastructure for asset management.
Enzyme was co-founded by Mona El Isa and Reto Trinkler, who established the project in 2016 under its original name, Melon. Mona El Isa previously served as a vice president and star trader at Goldman Sachs, bringing substantial traditional finance experience to the venture. Reto Trinkler is a blockchain developer who contributed technical expertise to the project's foundation. The project was initially developed by Melonport, a private company founded by Mona El Isa in 2016. Both founders brought complementary skills from their respective backgrounds in traditional finance and blockchain development. The project has maintained active development since its inception, with the official X account having joined in August 2016. The team has guided Enzyme through its rebranding from Melon Protocol in 2020 and continues to develop institutional-grade infrastructure for tokenized finance.
Enzyme operates as a decentralized platform that leverages blockchain technology to provide comprehensive and secure systems for managing digital assets. The platform's core infrastructure enables users to create, manage, and scale investment strategies through a unified application interface that simplifies access to digital assets and DeFi protocols. Enzyme deploys second-generation smart contracts that undergo strict testing and auditing before mainnet launch, ensuring platform security. The platform facilitates interaction with over 30 protocols and hundreds of assets within a single interface, offering built-in analytics, delegation, and automation features. Enzyme Onyx provides a modular architecture with open APIs, allowing tokenized products to be embedded directly into client interfaces for expanded distribution. The Vault as a Service offering enables deployment of institutional-grade tokenized vehicles with advanced tools and complete management controls. The platform supports various asset classes including cryptocurrencies, securities, commodities, Bitcoin, real-world assets, and stablecoins, while maintaining compliance-ready infrastructure covering MIFID II, MICAR, AIFMD, UCITS, SEC Regulation, and FCA Framework requirements.
Enzyme distinguishes itself through its comprehensive infrastructure for tokenized finance, combining institutional-grade security with flexible asset management capabilities. The platform has achieved SOC 2 certification, validating its security controls and data management processes through independent audit against rigorous industry standards. With over eight years of operational history in decentralized finance, Enzyme has demonstrated longevity and resilience in a rapidly evolving sector. The platform's Vault as a Service technology stack enables issuance and management of tokenized funds and instruments, while its Financial Instruments capability allows creation and trading of on-chain options, including customized covered calls and cash-secured puts. Enzyme's compliance framework addresses global regulatory standards across multiple jurisdictions, making it suitable for institutional adoption. The platform's expansion to Canton Network, with Franklin Templeton joining as a Super Validator and DTCC confirming its rollout, positions Enzyme as a key infrastructure layer for tokenized funds. The automation capabilities, demonstrated by reducing NAV calculation verification from 780 hours annually to automated processes, showcase tangible operational efficiency improvements for asset managers.
The MLN token serves multiple functions within the Enzyme ecosystem. Primarily, it is used for governance, allowing holders to participate in decisions affecting the platform's development and direction. MLN is also utilized for protocol fees, enabling users to pay for platform usage and services. Additionally, the token incentivizes specific behaviors that contribute to the health and growth of the ecosystem. Beyond token utility, the Enzyme platform itself supports various use cases including tokenized funds, where the complete technology stack enables launching tokenized hedge funds, money market funds, and mutual funds with flexibility to invest across centralized and decentralized markets. Financial Instruments allow clients to access fully tokenized innovative strategies operating seamlessly between decentralized and traditional asset classes. Tokenized Pools enable seamless attraction and integration of liquidity through incentives and fully decentralized vehicles. The platform serves financial service providers, issuers, capital allocators, portfolio managers, builders, and strategists seeking to create and manage next-generation financial products.
The Enzyme ecosystem continues to expand through strategic integrations and infrastructure development. A significant development involves the platform's expansion to Canton Network, where Enzyme Onyx will serve as the tokenized fund infrastructure layer. Franklin Templeton has joined Canton Network as a Super Validator, and DTCC, the largest post-trade infrastructure provider in the United States processing $4.7 quadrillion in securities transactions annually, has confirmed its rollout on Canton. The platform has obtained SOC 2 certification, demonstrating commitment to security and compliance standards. Enzyme has also established a webinar collaboration with Chainlink focused on deploying tokenized funds. The platform's modular architecture and open APIs enable embedding tokenized products directly into client interfaces, expanding distribution capabilities. Enzyme Onyx natively supports Ethereum Virtual Machine networks, Rayls, and Canton, providing multi-chain flexibility. The ecosystem interacts with over 30 protocols and hundreds of assets, while the Myso Protocol can be seamlessly integrated into products. With 161 active trading markets and listings across major platforms including Coinbase, Kraken, Binance, Crypto.com, MetaMask, Revolut, and TradingView, the ecosystem maintains broad accessibility for users.
Enzyme (MLN) operates on the Ethereum blockchain, which utilizes a proof-of-stake consensus mechanism following Ethereum's transition to proof-of-stake. MLN tokens cannot be mined through traditional proof-of-work mining processes. Instead, users can acquire MLN through trading on supported platforms or potentially through staking mechanisms where available. Some platforms offer staking services for MLN, allowing holders to potentially earn rewards. The token's utility focuses on governance and protocol fees rather than serving as a mining reward. Detailed public information regarding specific staking programs and reward structures should be verified through official Enzyme channels and documentation. Users interested in supporting the network should explore available staking options on platforms that list MLN, while understanding that the token's primary functions relate to platform governance and fee payment rather than network consensus participation.
Securing MLN tokens requires attention to both platform-level and personal security practices. Enzyme has implemented multiple security measures including SOC 2 certification, which independently validates the organization's security controls and data management processes against rigorous industry standards. The platform deploys second-generation smart contracts that undergo strict testing and auditing before mainnet deployment, with ongoing smart contract audits protecting the Vault infrastructure. For personal security, users should store MLN in reputable wallets that support Ethereum-based tokens, such as hardware wallets for enhanced protection against online threats. When interacting with DeFi protocols, users should verify contract addresses and platform legitimacy before approving transactions. Enzyme encourages users to conduct their own research and due diligence, noting that while the platform facilitates interactions, it does not take responsibility for underlying protocol operations, functionality, or security. Enabling two-factor authentication on exchange accounts, using strong unique passwords, and maintaining awareness of common phishing tactics further protects holdings. Regular software updates and cautious approval management help mitigate risks associated with smart contract interactions.
MLN is listed on select cryptocurrency exchanges and platforms. For a secure and liquid trading experience, using a major regulated platform like BTCC is recommended.
Register a BTCC Account: Sign up using your email or mobile number and complete the KYC verification to unlock more features and benefits of the platform.
Deposit Funds: Deposit fiat currency via bank transfer, card, or third-party payment, or transfer USDT from an external wallet into your BTCC account.
Start Trading: Go to the trading page and search for the spot trading pair MLN/USDT or the perpetual contract MLNUSDT.
Place an Order: Enter the amount of MLN you wish to purchase and submit the order. For contract trading, you can also choose to go short and adjust the leverage multiplier according to your strategy and risk tolerance.
Confirm Your Purchase: For spot purchases, check your personal account to see if the coins have arrived. For contract trades, check the trading page to see if your order was filled successfully.
Buy in just 4 steps (Register → Verify → Deposit/Purchase → Receive Coins)
Choose Enzyme products that suit your trading style
Thank you for your interest in BTCC. Currently, spot and futures trading services for MLN are not supported. As a leading digital asset platform, BTCC is committed to providing a secure and stable trading environment. We recommend completing your account registration and identity verification (KYC) to explore other premium assets and exclusive benefits available on BTCC.
As of right now, the live price of Enzyme (MLN) is $1.534438. Its market price fluctuates in real time based on overall supply and demand, and you can check the updated MLN to USD rate at the top of BTCC’s price page. In terms of market scope, Enzyme records a 24h trading volume of $36.466435K (reflecting total buying and selling activity over the last 24 hours), with a total market cap of $5.025991M. Its current circulating supply stands at 3.28M out of a maximum supply cap of ∞.
The price volatility of Enzyme (MLN) is essentially driven by market supply and demand dynamics. Key factors behind its price movements include: 1) Global macroeconomic conditions and sentiment, such as Fed interest rate decisions; 2) Tokenomics, including the ratio of circulating supply (3.28M) to max supply (∞), as well as token unlocks and burn mechanisms; 3) Fundamental developments, such as ecosystem expansion, on-chain activity, and core protocol upgrades; and 4) Derivatives market dynamics, including leverage battles and liquidation cascades in perpetual contracts.
Looking at its historical price performance, Enzyme (MLN) hit an all-time high (ATH) of $270.045013 on 2018-01-04 20:10, representing the peak of market sentiment. Conversely, its all-time low (ATL) was recorded at $1.18156 on 2026-06-25 14:05. Note that historical highs and lows reflect past performance only and do not guarantee future price trends; investment decisions should always align with live market conditions and your personal risk tolerance.
When trading MLN futures on BTCC, technical chart analysis begins with identifying key support and resistance levels on 1D and 4H charts using historical price pivots. Next, apply MA/EMA indicators to gauge trend directions, alongside RSI (values above 70 indicate overbought conditions, while below 30 suggest oversold levels). Always validate breakout signals with the 24h trading volume ($36.466435K), as price breakouts accompanied by strong volume offer higher reliability.
Unlike spot trading where you can only profit from rising prices, BTCC’s MLNUSDT perpetual contracts support two-way trading. If you anticipate a price decline for Enzyme, simply log into your BTCC account with USDT margin available, navigate to the MLNUSDT pair, set your desired leverage and Take-Profit/Stop-Loss levels, and click "Sell/Short". Once the price drops to your target, close your position to lock in profit from the price difference.
Yes. BTCC offers flexible, high-tier leverage options for MLNUSDT perpetual futures, providing up to 500x leverage (maximum leverage limits may vary depending on liquidity). While leverage boosts capital efficiency by allowing you to control larger position sizes with less margin, it also amplifies liquidation risks proportionately. BTCC strongly advises using Stop-Loss orders to strictly manage risk when trading with high leverage.
Beginners and traders testing new strategies can switch to BTCC's "Demo Trading" mode with a single click on the App or Web interface. The demo account comes pre-loaded with risk-free virtual funds (such as 100,000 USDT). Powered by live market prices (current price: $1.534438), you can practice opening/closing positions, adjusting leverage, and setting TP/SL for MLNUSDT with zero financial risk.
Trading Enzyme (MLN) on BTCC requires just 4 simple steps: 1) Register a BTCC account and complete basic Identity Verification (KYC); 2) Buy USDT using fiat via credit card/express payment, or deposit USDT/BTC directly from an external wallet; 3) Navigate to the Futures section, search for MLNUSDT, and review its live price ($1.534438) and chart; 4) Select your margin mode and leverage, choose "Buy/Long" or "Sell/Short" based on your market outlook, set TP/SL orders, and confirm your trade.
Cryptocurrency prices are subject to high market risk and price volatility. You should only invest in products that you are familiar with and where you understand the associated risks. The content expressed on this page is not intended to be and shall not be construed as an endorsement by BTCC regarding the reliability or accuracy of such content. You should carefully consider your investment experience, financial situation, investment objectives, and risk tolerance, and consult an independent financial adviser before making any investment. This material should not be construed as financial advice. Past performance is not a reliable indicator of future performance. The value of your investment can go down as well as up, and you may not get back the amount you invested. You are solely responsible for your investment decisions. BTCC is not responsible for any losses you may incur. For more information, please refer to our Terms of Use and Risk Warning. Please also note that data relating to the above-mentioned cryptocurrency presented here (such as its current live price) are based on third-party sources. They are presented to you on an “as is” basis and for informational purposes only, without representation or warranty of any kind. Links provided to third-party sites are also not under BTCC’s control. BTCC is not responsible for the reliability or accuracy of such third-party sites or their contents.
Bitcoin
Ethereum
Tether USDt
BNB
XRP
Solana
Dogecoin
Cardano
Avalanche
